Skip to main content

Find Clinical Trials

Home
Conditions
Active, Moderate to Severe Rheumatoid Arthritis

Clinical trial condition

Active, Moderate to Severe Rheumatoid Arthritis

Explore clinical trials studying Active, Moderate to Severe Rheumatoid Arthritis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Active, Moderate to Severe Rheumatoid Arthritis trial results

Completed

A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes

NCT00642629

Conditions: Active, Moderate to Severe Rheumatoid Arthritis, Behavior, Motor Activity
Locations: Academic Medical Center Amsterdam, Netherlands

View Trial Details